{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:17:55Z","timestamp":1791224275844,"version":"4.1.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:00:00Z","timestamp":1636588800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20\/00690"],"award-info":[{"award-number":["PI20\/00690"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI17\/01089"],"award-info":[{"award-number":["PI17\/01089"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["CD18\/00158"],"award-info":[{"award-number":["CD18\/00158"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["602156"],"award-info":[{"award-number":["602156"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Food and Chemical Toxicology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.fct.2021.112664","type":"journal-article","created":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T03:11:09Z","timestamp":1636427469000},"page":"112664","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Molecular mechanisms of hepatotoxic cholestasis by clavulanic acid: Role of NRF2 and FXR pathways"],"prefix":"10.1016","volume":"158","author":[{"given":"Petar D.","family":"Petrov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polina","family":"Soluyanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"S\u00e1nchez-Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 V.","family":"Castell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramiro","family":"Jover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fct.2021.112664_bib1","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1128\/AAC.22.3.353","article-title":"Pharmacokinetics of amoxicillin and clavulanic acid administered alone and in combination","volume":"22","author":"Adam","year":"1982","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.fct.2021.112664_bib2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/17843286.1991.11718184","article-title":"Intrahepatic cholestasis induced by amoxicillin\/clavulanic acid (Augementin\u00ae): a report on two cases","volume":"46","author":"Alexander","year":"1991","journal-title":"Acta Clin. Belg."},{"key":"10.1016\/j.fct.2021.112664_bib3","doi-asserted-by":"crossref","first-page":"28857","DOI":"10.1074\/jbc.M011610200","article-title":"Human bile salt export pump promoter is transactivated by the farnesoid X receptor\/bile acid receptor","volume":"276","author":"Ananthanarayanan","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.fct.2021.112664_bib4","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.gastro.2005.05.006","article-title":"Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period","volume":"129","author":"Andrade","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.fct.2021.112664_bib5","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1002\/hep.26160","article-title":"Oxidative stress plays a major role in chlorpromazine-induced cholestasis in human HepaRG cells","volume":"57","author":"Anth\u00e9rieu","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.fct.2021.112664_bib6","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1124\/mol.114.096313","article-title":"Repression of the nuclear receptor small heterodimer partner by steatotic drugs and in advanced nonalcoholic fatty liver disease","volume":"87","author":"Benet","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.fct.2021.112664_bib7","doi-asserted-by":"crossref","first-page":"8789","DOI":"10.3748\/wjg.v19.i46.8789","article-title":"Acute cholestatic hepatitis caused by amoxicillin\/clavulanate","volume":"19","author":"Beraldo","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.fct.2021.112664_bib8","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1053\/j.gastro.2013.02.006","article-title":"Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland","volume":"144","author":"Bjornsson","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.fct.2021.112664_bib9","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1053\/j.gastro.2010.04.001","article-title":"Risk factors for idiosyncratic drug-induced liver injury","volume":"138","author":"Chalasani","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.fct.2021.112664_bib10","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1053\/j.gastro.2015.03.006","article-title":"Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study","volume":"148","author":"Chalasani","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.fct.2021.112664_bib11","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1053\/j.gastro.2008.09.011","article-title":"Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States","volume":"135","author":"Chalasani","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.fct.2021.112664_bib12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0022-3476(00)90064-7","article-title":"Rapidly progressive cholestasis: an unusual reaction to amoxicillin\/clavulanic acid therapy in a child","volume":"136","author":"Chawla","year":"2000","journal-title":"J. Pediatr."},{"key":"10.1016\/j.fct.2021.112664_bib13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.livres.2020.05.001","article-title":"Up to date on cholesterol 7 alpha-hydroxylase (CYP7A1) in bile acid synthesis","volume":"4","author":"Chiang","year":"2020","journal-title":"Liver Res"},{"key":"10.1016\/j.fct.2021.112664_bib14","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2019.01.034","article-title":"A missense variant in PTPN22 is a risk factor for drug-induced liver injury","volume":"156","author":"Cirulli","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.fct.2021.112664_bib15","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0895-4356(93)90101-6","article-title":"Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries","volume":"46","author":"Danan","year":"1993","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.fct.2021.112664_bib16","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2125.2004.02133.x","article-title":"Acute and clinically relevant drug-induced liver injury: a population case-control study","author":"De Abajo","year":"2004","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.fct.2021.112664_bib17","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1002\/jps.23933","article-title":"Confocal imaging with a fluorescent bile acid analogue closely mimicking hepatic taurocholate disposition","volume":"103","author":"De Bruyn","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.fct.2021.112664_bib18","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1007\/s10620-016-4121-6","article-title":"Amoxicillin\u2013clavulanate-induced liver injury","volume":"61","author":"DeLemos","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.fct.2021.112664_bib19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.59566\/IJBS.2016.12071","article-title":"Oxidative stress alleviation by sage essential oil in Co-amoxiclav induced hepatotoxicity in rats","volume":"12","author":"El-Hosseiny","year":"2016","journal-title":"Int. J. Biomed. Sci."},{"key":"10.1016\/j.fct.2021.112664_bib20","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S1665-2681(19)31792-2","article-title":"Role of ursodeoxycholic acid in prevention of hepatotoxicity caused by amoxicillin-clavulanic acid in rats","volume":"8","author":"El-Sherbiny","year":"2009","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.fct.2021.112664_bib21","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1007\/s10620-005-2938-5","article-title":"Acute liver failure due to amoxicillin and amoxicillin\/clavulanate","volume":"50","author":"Fontana","year":"2005","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.fct.2021.112664_bib22","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1194\/jlr.M300215-JLR200","article-title":"Structure-activity relationship of bile acids and bile acid analogs in regard to FXR activation","volume":"45","author":"Fujino","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.fct.2021.112664_bib23","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1194\/jlr.D028803","article-title":"Targeted profiling of circulating and hepatic bile acids in human, mouse, and rat using a UPLC-MRM-MS-validated method","volume":"53","author":"Garcia-Canaveras","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.fct.2021.112664_bib24","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1124\/dmd.113.054189","article-title":"The role of bile salt export pump gene repression in drug-induced cholestatic liver toxicity","volume":"42","author":"Garzel","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.fct.2021.112664_bib25","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.3748\/wjg.15.3134","article-title":"Serum bile acid profiling reflects enterohepatic detoxification state and intestinal barrier function in inflammatory bowel disease","volume":"15","author":"Gnewuch","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.fct.2021.112664_bib26","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1124\/mol.114.092262","article-title":"Differential effects of membrane cholesterol content on the transport activity of multidrug resistance\u2013associated protein 2 ( ABCC2 ) and of the bile salt export pump ( ABCB11 )","volume":"85","author":"Guyot","year":"2014","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.fct.2021.112664_bib27","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0016-5085(99)70404-X","article-title":"HLA association of amoxicillin-clavulanate-induced hepatitis","volume":"117","author":"Hautekeete","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.fct.2021.112664_bib28","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tibs.2014.02.002","article-title":"The Nrf2 regulatory network provides an interface between redox and intermediary metabolism","volume":"39","author":"Hayes","year":"2014","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.fct.2021.112664_bib29","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00204-020-02669-7","article-title":"In vitro prediction of organ toxicity: the challenges of scaling and secondary mechanisms of toxicity","volume":"94","author":"Hengstler","year":"2020","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.fct.2021.112664_bib30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cld.2016.08.005","article-title":"Adverse drug reactions: type A (intrinsic) or type B (idiosyncratic)","volume":"21","author":"Iasella","year":"2017","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.fct.2021.112664_bib31","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/hep.28965","article-title":"The ascending pathophysiology of cholestatic liver disease","volume":"65","author":"Jansen","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.fct.2021.112664_bib32","doi-asserted-by":"crossref","first-page":"D712","DOI":"10.1093\/nar\/gkq1156","article-title":"ConsensusPathDB: toward a more complete picture of cell biology","volume":"39","author":"Kamburov","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.fct.2021.112664_bib33","series-title":"Topics in Current Chemistry","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/128_2012_339","article-title":"Keap1\u2013Nrf2 signaling: a target for cancer prevention by sulforaphane","author":"Kensler","year":"2012"},{"key":"10.1016\/j.fct.2021.112664_bib34","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1152\/ajpgi.00430.2005","article-title":"The nuclear receptor for bile acids, FXR, transactivates human organic solute transporter-\u03b1 and -\u03b2 genes","volume":"290","author":"Landrier","year":"2006","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.fct.2021.112664_bib35","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1194\/jlr.M039404","article-title":"Regulation of human class i alcohol dehydrogenases by bile acids","volume":"54","author":"Langhi","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.fct.2021.112664_bib36","article-title":"Overexpression of cholesterol 7\u03b1-hydroxylase promotes hepatic bile acid synthesis and secretion and maintains cholesterol homeostasis","author":"Li","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.fct.2021.112664_bib37","first-page":"30","article-title":"Antibiotic-induced elevations of plasma bile acids in rats independent of Bsep inhibition","volume":"157","author":"Li","year":"2017","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.fct.2021.112664_bib38","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1345\/aph.18104","article-title":"Amoxicillin\/clavulanate-associated hepatic failure with progression to Stevens-Johnson syndrome","volume":"33","author":"Limauro","year":"1999","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.fct.2021.112664_bib39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fphar.2017.00003","article-title":"New microRNA biomarkers for drug-induced steatosis and their potential to predict the contribution of drugs to non-alcoholic fatty liver disease","volume":"8","author":"L\u00f3pez-Riera","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.fct.2021.112664_bib40","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/hep.21324","article-title":"Determinants of the clinical expression of amoxicillin-clavulanate hepatotoxicity: a prospective series from Spain","volume":"44","author":"Lucena","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.fct.2021.112664_bib41","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1053\/j.gastro.2011.04.001","article-title":"Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles","volume":"141","author":"Lucena","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.fct.2021.112664_bib42","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1124\/mol.116.103390","article-title":"Role of multidrug resistance protein 3 in antifungal-induced cholestasis","volume":"90","author":"Mahdi","year":"2016","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.fct.2021.112664_bib43","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1124\/dmd.105.008748","article-title":"Inhibition of bile acid transport across Na+\/taurocholate cotransporting polypeptide (SLC10A1) and bile salt export pump (ABCB 11)-coexpressing LLC-PK1 cells by cholestasis-inducing drugs","volume":"34","author":"Mita","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.fct.2021.112664_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2010.01.008","article-title":"Enhanced steatosis by nuclear receptor ligands: a study in cultured human hepatocytes and hepatoma cells with a characterized nuclear receptor expression profile","volume":"184","author":"Moya","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.fct.2021.112664_bib45","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.freeradbiomed.2013.02.008","article-title":"Regulation of Nrf2\u2014an update","volume":"66","author":"Niture","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.fct.2021.112664_bib46","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/toxsci\/kft197","article-title":"Early identification of clinically relevant drug interactions with the human bile salt export pump (BSEP\/ABCB11)","volume":"136","author":"Pedersen","year":"2013","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.fct.2021.112664_bib47","first-page":"102","article-title":"[Augmentin hepatotoxicity: responsibility of clavulanic acid? Apropos of a case]","volume":"16","author":"Peroux","year":"1992","journal-title":"Gastroenterol. Clin. Biol."},{"key":"10.1016\/j.fct.2021.112664_bib48","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00204-019-02643-y","article-title":"Epistane, an anabolic steroid used for recreational purposes, causes cholestasis with elevated levels of cholic acid conjugates, by upregulating bile acid synthesis (CYP8B1) and cross-talking with nuclear receptors in human hepatocytes","volume":"94","author":"Petrov","year":"2020","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.fct.2021.112664_bib49","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/0016-5085(89)91633-8","article-title":"Amoxicillin-clavulanate potassium-associated cholestasis","volume":"96","author":"Reddy","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1016\/j.fct.2021.112664_bib50","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1023\/A:1026610015899","article-title":"Prolonged cholestasis with ductopenia after administration of amoxicillin\/clavulanic acid","volume":"44","author":"Richardet","year":"1999","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.fct.2021.112664_bib51","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S1665-2681(19)31884-8","article-title":"Oxidative stress: a radical way to stop making bile","volume":"7","author":"Roma","year":"2008","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.fct.2021.112664_bib52","doi-asserted-by":"crossref","DOI":"10.4321\/S1130-01082012001100016","article-title":"Recurrent cholestasis by amoxicillin-clavulanic acid: the importance of a correct diagnosis of hepatotoxicity","author":"S\u00e1nchez-Ruiz-Granados","year":"2012","journal-title":"Rev. Esp. Enferm. Dig."},{"key":"10.1016\/j.fct.2021.112664_bib53","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1124\/dmd.115.067348","article-title":"Upcyte human hepatocytes: a potent in vitro tool for the prediction of hepatic clearance of metabolically stable compounds","volume":"44","author":"Schaefer","year":"2016","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.fct.2021.112664_bib54","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1016\/j.jchromb.2009.09.038","article-title":"Rapid quantification of bile acids and their conjugates in serum by liquid chromatography-tandem mass spectrometry","volume":"877","author":"Scherer","year":"2009","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.fct.2021.112664_bib55","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3177\/jnsv.61.154","article-title":"Selective regulation of FGF19 and FGF21 expression by cellular and nutritional stress","volume":"61","author":"Shimizu","year":"2015","journal-title":"J. Nutr. Sci. Vitaminol. (Tokyo)."},{"key":"10.1016\/j.fct.2021.112664_bib56","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.2304","article-title":"Fluorometric estimation of glutathione in cultured microglial cell lysate","volume":"7","author":"Singh","year":"2017","journal-title":"Bio-Protocol"},{"key":"10.1016\/j.fct.2021.112664_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068111","article-title":"HLA alleles influence the clinical signature of amoxicillin-clavulanate hepatotoxicity","volume":"8","author":"Stephens","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.fct.2021.112664_bib58","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jhep.2021.01.029","article-title":"Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry","volume":"75","author":"Stephens","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.fct.2021.112664_bib59","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1007\/BF01537113","article-title":"Cholestatic hepatitis due to antibacterial combination of amoxicillin and clavulanic acid (Augmentin)","volume":"34","author":"Stricker","year":"1989","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.fct.2021.112664_bib60","article-title":"Intrahepatic cholestasis due to ticarcillin\u2010clavulanate","author":"Sweet","year":"1995","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.fct.2021.112664_bib61","doi-asserted-by":"crossref","first-page":"6215","DOI":"10.1158\/0008-5472.CAN-17-2039","article-title":"FGF19 protects hepatocellular carcinoma cells against endoplasmic reticulum stress via activation of FGFR4\u2013GSK3\u03b2\u2013Nrf2 signaling","volume":"77","author":"Teng","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.fct.2021.112664_bib62","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/toxsci\/kfw078","article-title":"Human upcyte hepatocytes: characterization of the hepatic phenotype and evaluation for acute and long-term hepatotoxicity routine testing","volume":"152","author":"Tolosa","year":"2016","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.fct.2021.112664_bib63","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.dld.2011.10.025","article-title":"Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a pilot study","volume":"44","author":"Trottier","year":"2012","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.fct.2021.112664_bib64","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/hep.26012","article-title":"Monitoring bile acid transport in single living cells using a genetically encoded F\u00f6rster resonance energy transfer sensor","volume":"57","author":"van der Velden","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.fct.2021.112664_bib65","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/0168-8278(89)90061-5","article-title":"Cholestatic hepatitis due to an amoxycillin\/clavulanic acid preparation","volume":"9","author":"Verhamme","year":"1989","journal-title":"J. Hepatol."},{"key":"10.1016\/j.fct.2021.112664_bib66","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1042\/BJ20051518","article-title":"Role of Nrf2 in the regulation of the Mrp2 (ABCC2) gene","volume":"395","author":"Vollrath","year":"2006","journal-title":"Biochem. J."},{"key":"10.1016\/j.fct.2021.112664_bib67","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/cpt.2108","article-title":"Clinical characteristics and outcome of drug-induced liver injury in the older patients: from the young-old to the oldest-old","volume":"109","author":"Weersink","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.fct.2021.112664_bib68","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.tiv.2009.08.009","article-title":"Use of cassette dosing in sandwich-cultured rat and human hepatocytes to identify drugs that inhibit bile acid transport","volume":"24","author":"Wolf","year":"2010","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.fct.2021.112664_bib69","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.canlet.2020.11.032","article-title":"Small hepatitis B virus surface antigen promotes malignant progression of hepatocellular carcinoma via endoplasmic reticulum stress-induced FGF19\/JAK2\/STAT3 signaling","volume":"499","author":"Wu","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.fct.2021.112664_bib70","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jchromb.2009.11.019","article-title":"High performance liquid chromatography-tandem mass spectrometry for the determination of bile acid concentrations in human plasma","volume":"878","author":"Xiang","year":"2009","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.fct.2021.112664_bib71","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/toxsci\/kfn109","article-title":"Cellular imaging predictions of clinical drug-induced liver injury","volume":"105","author":"Xu","year":"2008","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.fct.2021.112664_bib72","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2133\/dmpk.25.214","article-title":"Measurement of bile salt export pump transport activities using a fluorescent bile acid derivative","volume":"25","author":"Yamaguchi","year":"2010","journal-title":"Drug Metabol. Pharmacokinet."},{"key":"10.1016\/j.fct.2021.112664_bib73","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/hep4.1064","article-title":"Idiosyncratic drug-induced liver injury: a short review","volume":"1","author":"Yamashita","year":"2017","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.fct.2021.112664_bib74","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.bbadis.2010.10.006","article-title":"Role of nuclear receptor SHP in metabolism and cancer","volume":"1812","author":"Zhang","year":"2011","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.fct.2021.112664_bib75","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000365003","article-title":"Alterations of canalicular ATP-binding cassette transporter expression in drug-induced liver injury","volume":"90","author":"Zollner","year":"2014","journal-title":"Digestion"}],"container-title":["Food and Chemical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691521006979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691521006979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T14:24:46Z","timestamp":1778682286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278691521006979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":75,"alternative-id":["S0278691521006979"],"URL":"https:\/\/doi.org\/10.1016\/j.fct.2021.112664","relation":{},"ISSN":["0278-6915"],"issn-type":[{"value":"0278-6915","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular mechanisms of hepatotoxic cholestasis by clavulanic acid: Role of NRF2 and FXR pathways","name":"articletitle","label":"Article Title"},{"value":"Food and Chemical Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fct.2021.112664","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"112664"}}